BACKGROUND: Desmoplastic melanoma (DM) has been associated with higher local recurrence rates than other types of cutaneous melanoma. Current controversies regarding locoregional treatment strategies warrant further investigation. METHODS: Retrospective review of a prospectively maintained melanoma database identified 129 patients with DM out of \u3e12,500 melanoma patients referred for treatment from 1980 to 2003. Clinical and histopathologic characteristics, recurrence, and survival were analyzed. RESULTS: The median follow-up was 4.0 years. Of the 129 patients identified, 82 (63.6%) were male, and the median age was 55.2 years. American Joint Committee on Cancer staging was I, II, and III in 25.6%, 68.0%, and 6.4% of patients, respective...
melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis ...
Background: Desmoplastic melanoma (DM) is an uncommon type of melanoma. Two histological subtypes of...
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the ris...
BACKGROUND: Desmoplastic melanoma (DM) has been associated with higher local recurrence rates than o...
BACKGROUND: Pure desmoplastic melanoma (pDM) is an uncommon subtype of malignant melanoma with compa...
Desmoplastic melanoma is a unique subtype of melanoma which typically affects older patients who oft...
Studies of the immunohistochemical profiles and clinical course of desmoplastic melanoma have produc...
Desmoplastic melanoma is an uncommonly encountered variant of malignant melanoma. Three histological...
Background and Objectives Desmoplastic melanoma is a unique subtype of melanoma which typically affe...
<p>A. RFS by age (≥70 vs. <70 years). B. RFS by gender. C. RFS by presence or absence of perineural ...
Objective: To investigate stage-specific survival from diagnosis, stage-specific disease recurrence,...
BACKGROUND Adjuvant radiation has been proposed for the treatment of patients with desmoplastic mel...
Objective: Information on prognosis for patients with cutaneous melanoma after locoregional or dista...
Background: While curable at early stages, few treatment options exist for advanced melanoma. Curren...
While curable at early stages, few treatment options exist for advanced melanoma. Currently, no cons...
melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis ...
Background: Desmoplastic melanoma (DM) is an uncommon type of melanoma. Two histological subtypes of...
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the ris...
BACKGROUND: Desmoplastic melanoma (DM) has been associated with higher local recurrence rates than o...
BACKGROUND: Pure desmoplastic melanoma (pDM) is an uncommon subtype of malignant melanoma with compa...
Desmoplastic melanoma is a unique subtype of melanoma which typically affects older patients who oft...
Studies of the immunohistochemical profiles and clinical course of desmoplastic melanoma have produc...
Desmoplastic melanoma is an uncommonly encountered variant of malignant melanoma. Three histological...
Background and Objectives Desmoplastic melanoma is a unique subtype of melanoma which typically affe...
<p>A. RFS by age (≥70 vs. <70 years). B. RFS by gender. C. RFS by presence or absence of perineural ...
Objective: To investigate stage-specific survival from diagnosis, stage-specific disease recurrence,...
BACKGROUND Adjuvant radiation has been proposed for the treatment of patients with desmoplastic mel...
Objective: Information on prognosis for patients with cutaneous melanoma after locoregional or dista...
Background: While curable at early stages, few treatment options exist for advanced melanoma. Curren...
While curable at early stages, few treatment options exist for advanced melanoma. Currently, no cons...
melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis ...
Background: Desmoplastic melanoma (DM) is an uncommon type of melanoma. Two histological subtypes of...
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the ris...